# Abbott Laboratories (ABT) — Q3-2014 Earnings Results

**Report date:** 2014-10-22 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q3-2014

## Post-Earnings Brief

### Headline

Abbott Labs Misses on EPS, Stock Down 1.89%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.54 | N/A | -9.85% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management acknowledged the tough environment but expressed confidence in their long-term strategy. They are committed to improving operational efficiency.

**Key quotes:**

> Management highlighted ongoing challenges in the market.

> They emphasized a focus on innovation and cost management.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Abbott Labs reported earnings that fell short of expectations, leading to a decline in stock price by 1.89%. The miss on EPS suggests that the company is facing some challenges, which may affect investor confidence. However, management's focus on innovation and cost management indicates they are working to navigate these issues moving forward.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q3-2014_